Clinical trial
Capecitabine as Maintenance Therapy vs Observation in Early-stage Triple-negative Breast Cancer
NCT07143097
Study timeline
Study start (actual)2021-11-01Date precision: day
Registry last updated2025-08-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Triple -Negative Breast Cancerunresolved
Interventions
capecitabineDRUG · verified · RxNorm: capecitabine
Sponsors & collaborators
Beni-Suef Universitylead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07143097 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.